Fumitaka Ichida

988 citations
7 papers · 839 indexed · h-index 6
Topics
Bone Metabolism and Diseases (4 papers)Bone health and treatments (3 papers)Cancer-related gene regulation (2 papers)
Partner nations
JapanUnited States

In The Last Decade

Fumitaka Ichida

7 papers receiving 830 citations

Peers

Fumitaka Ichida
Comparison fields: 5 of 77
  • Molecular Biology 585
  • Oncology 175
  • Rheumatology 173
  • Genetics 109
  • Cancer Research 102
Replace Gwan-Shik Kim with:
Gwan-Shik Kim South Korea
Won‐Joon Yoon South Korea
Soraya Gutiérrez United States
Yoshinobu Higuchi Japan
Kyeong‐Sook Lee South Korea
Beatriz Gámez Spain
Vincent Kuek Australia
Hiroko Meguro Japan
Yasuto Taguchi United States
M Sabatini United States
Fumitaka Ichida relative to Gwan-Shik Kim South Korea Gwan-Shik Kim's profile →
Citations per field
00.5×1.5×2.3×
Gwan-Shik Kim · 1×
Citations per year

Countries citing papers authored by Fumitaka Ichida

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Ichida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Ichida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Ichida more than expected).

Fields of papers citing papers by Fumitaka Ichida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Ichida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Ichida. The network helps show where Fumitaka Ichida may publish in the future.

Co-authorship network of co-authors of Fumitaka Ichida

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Ichida. A scholar is included among the top collaborators of Fumitaka Ichida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Ichida. Fumitaka Ichida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 45
2 80
3 446
4 35
5 76
6
[Roles of PPAR family in bone metabolisms].
1
7 156

About Fumitaka Ichida

Fumitaka Ichida is a scholar working on Cancer Research, Oncology and Genetics, having authored 7 papers that have together received 839 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (4 papers), Bone health and treatments (3 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Rheumatology (173 citations), Genetics (109 citations) and Molecular Biology (585 citations). Fumitaka Ichida has collaborated with scholars based in Japan and United States. Frequent co-authors include Riko Nishimura, Toshiyuki Yoneda, Kenji Hata, Takuma Matsubara, Akira Yamaguchi, Hiroko Meguro, Kumiko Kida, Hiroyuki Aburatani, Fumiyo Ikeda and Xu Cao. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Bone and Mineral Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026